Disclosure Of Entity's Operating Segments [Text Block]

Hofseth BioCare ASA - Filing #5833258

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of entity's operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Share of profit (loss) of associates and joint ventures accounted for using equity method	—	—	7 484 NOK	—	—	—	—	—	2 541 NOK	—	—	—	—	—
Tax expense (income)	—	—	0 NOK	—	—	—	—	—	0 NOK	—	—	—	—	—
Profit (loss) before tax	—	—	125 300 NOK	—	—	—	—	—	106 684 NOK	—	—	—	—	—
Profit (loss)	0 NOK	2,000 NOK	125 300 NOK	0 NOK	125 298 NOK	—	0 NOK	0 NOK	106 684 NOK	0 NOK	0 NOK	—	1,000 NOK	106 682 NOK
Assets	—	—	—	—	—	339 422 NOK	—	—	—	—	—	390 119 NOK	—	—
Investments accounted for using equity method	—	—	—	—	—	45 699 NOK	—	—	—	—	—	37 691 NOK	—	—
Liabilities	—	—	—	—	—	280 067 NOK	—	—	—	—	—	348 979 NOK	—	—
Cash flows from (used in) operating activities	—	—	9 780 NOK	—	—	—	—	—	2 761 NOK	—	—	—	—	—
Cash flows from (used in) investing activities	—	—	4 074 NOK	—	—	—	—	—	14 992 NOK	—	—	—	—	—
Cash flows from (used in) financing activities	—	—	15 539 NOK	—	—	—	—	—	3 694 NOK	—	—	—	—	—